High Time to Consider the Role of Thyroid Function in Single Ventricle Heart Disease

Dean S Karahalios1, Swati Sehgal2

  • 1Central Michigan University and Children's Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI, 48201, USA. dkarahal@dmc.org.

PubMed

Insights

The US FDA recommends thyroid testing after iodinated contrast media exposure in children. For single ventricle heart disease patients, thyroid hormone

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Radiology

Background:

  • The United States Food and Drug Administration (FDA) issued a recommendation for thyroid function testing in children up to 3 years old within 3 weeks of exposure to iodinated contrast media (ICM).
  • Thyroid hormone significantly impacts the cardiovascular system, and patients with congenital heart disease have an elevated risk of thyroid disease.
  • The Fontan circulation, a surgical procedure for single ventricle heart disease, has hemodynamic consequences that may affect the thyroid gland.

Purpose of the Study:

  • To respond to the FDA's recommendation regarding thyroid function testing after ICM exposure in children.
  • To discuss the potential clinical significance of subclinical hypothyroidism in the context of cardiovascular health.
  • To emphasize the importance of considering cardiovascular effects of thyroid hormone in patients with single ventricle heart disease.

Main Methods:

  • This study presents a perspective and opinion based on existing knowledge.
  • It involves a critical review of the FDA's recommendation in relation to pediatric cardiovascular conditions.
  • The authors consider the interplay between thyroid function, cardiovascular health, and specific patient populations.

Main Results:

  • The authors argue that the cardiovascular effects of thyroid hormone may be particularly influential in patients with single ventricle heart disease.
  • The FDA's recommendation prompts consideration for routine thyroid hormone surveillance in this specific patient group.
  • Subclinical hypothyroidism could have significant clinical implications for these vulnerable patients.

Conclusions:

  • The FDA's recommendation highlights the need for careful consideration of thyroid function testing in children exposed to ICM.
  • Routine thyroid hormone surveillance should be considered in the long-term management of patients with single ventricle heart disease.
  • This approach may help mitigate potential cardiovascular complications associated with thyroid dysfunction in this population.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
24
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12